Bioassay of Interleukin 1 (IL-1) in Human Gingival Crevicular Fluid During Experimental Gingivitis
Overview
Affiliations
The cytokine IL-1 was demonstrated in crevicular fluid during a 14- and 21-day experimental gingivitis in healthy human volunteers. A sensitive and specific bioassay allowed detection of biologically active IL-1 at levels ranging from 0.18 ng/microliters at baseline to 1.70 ng/microliters in inflamed gingiva. Levels of IL-1 increased rapidly with plaque accumulation and in advance of the subsequent gingival inflammation, peaking within 7 days of the start of gingivitis. As changes in IL-1 were detected before clinically recognizable gingival changes, IL-1 may have potential as an early marker of gingival inflammatory changes.
Biomaterials Functionalized with Inflammasome Inhibitors-Premises and Perspectives.
Vinteler N, Feurdean C, Petkes R, Barabas R, Bosca B, Muntean A J Funct Biomater. 2024; 15(2).
PMID: 38391885 PMC: 10889089. DOI: 10.3390/jfb15020032.
Metcalfe S, Panasiewicz M, Kay J J Leukoc Biol. 2023; 114(4):347-357.
PMID: 37497744 PMC: 10533225. DOI: 10.1093/jleuko/qiad089.
IL-1β strengthens the physical barrier in gingival epithelial cells.
Stolte K, Pelz C, Yapto C, Raguse J, Dommisch H, Danker K Tissue Barriers. 2020; 8(3):1804249.
PMID: 32835592 PMC: 7549743. DOI: 10.1080/21688370.2020.1804249.
Resistance and resilience to experimental gingivitis: a systematic scoping review.
Zemouri C, Jakubovics N, Crielaard W, Zaura E, Dodds M, Schelkle B BMC Oral Health. 2019; 19(1):212.
PMID: 31511002 PMC: 6737651. DOI: 10.1186/s12903-019-0889-z.
Danger signals in oral cavity-related diseases.
Kay J, Kramer J, Visser M J Leukoc Biol. 2019; 106(1):193-200.
PMID: 30776147 PMC: 6597288. DOI: 10.1002/JLB.4MIR1118-439R.